Post by
BioTeck on May 26, 2022 2:12pm
Procyon
This company Procyon was able to get a deal with Novo Nordisk with their version of the Cell Pouch which is clearly much inferior 2 years ago. Makes you wonder why Sernova took so long to get something papered. I hope we aren't the Ballard of BioTech.
https://procyon-technologies.com/stem-cell-based-therapy-for-type-1-diabetes/
On a side note, this area is heating up, there are so many new companies trying to do the same thing all over the world. I hope Sernova is able to maintain the headstart. Maybe with Evotec on board and on the board, they'll get things done quicker as Evotecs stock has literally fallen 50% in the last 6 months.